review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Melissa B Rogers | |
Tapan A Shah | |||
Nadia N Shaikh | |||
P2860 | cites work | A large-scale analysis of mRNA polyadenylation of human and mouse genes | Q24557438 |
miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1 | Q24657866 | ||
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro | Q24675778 | ||
Coordinating tissue interactions: Notch signaling in cardiac development and disease | Q26822995 | ||
Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis | Q28209599 | ||
Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2 | Q28591491 | ||
The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling | Q28593888 | ||
HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis | Q30176413 | ||
Cloning and functional characterization of the 5'-flanking region of the human bone morphogenetic protein-2 gene | Q30635527 | ||
Repressive BMP2 gene regulatory elements near the BMP2 promoter | Q33653895 | ||
Epigenetic modifications and canonical wingless/int-1 class (WNT) signaling enable trans-differentiation of nonosteogenic cells into osteoblasts | Q33931182 | ||
Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts | Q33939715 | ||
Molecular evolution at the decapentaplegic locus in Drosophila. | Q33969369 | ||
Differences in fat and muscle mass associated with a functional human polymorphism in a post-transcriptional BMP2 gene regulatory element. | Q34103291 | ||
Expression of BMP-2 and Ets1 in BMP-2-stimulated mouse pre-osteoblast differentiation is regulated by microRNA-370. | Q34275107 | ||
An autonomous BMP2 regulatory element in mesenchymal cells | Q34343759 | ||
Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. | Q34353340 | ||
Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification | Q34688816 | ||
Mycoplasma infection transforms normal lung cells and induces bone morphogenetic protein 2 expression by post-transcriptional mechanisms | Q34721898 | ||
Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. | Q35077692 | ||
Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice | Q35640633 | ||
Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors | Q35915965 | ||
An in vivo map of bone morphogenetic protein 2 post-transcriptional repression in the heart | Q36145780 | ||
GATA-6 promotes cell survival by up-regulating BMP-2 expression during embryonic stem cell differentiation | Q36234535 | ||
Structure and sequence of mouse bone morphogenetic protein-2 gene (BMP-2): comparison of the structures and promoter regions of BMP-2 and BMP-4 genes | Q36732898 | ||
Dynamics and cellular localization of Bmp2, Bmp4, and Noggin transcription in the postnatal mouse skeleton | Q36757294 | ||
Bone morphogenetic protein 2 transcripts in rapidly developing deer antler tissue contain an extended 5' non-coding region arising from a distal promoter | Q36843152 | ||
Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis | Q37037233 | ||
c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis | Q37112666 | ||
Species-specific cis-regulatory elements in the 3'-untranslated region direct alternative polyadenylation of bone morphogenetic protein 2 mRNA. | Q37141487 | ||
Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. | Q37156002 | ||
Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. | Q37906474 | ||
E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. | Q38304702 | ||
MicroRNA expression signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells | Q38483578 | ||
Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells | Q38997362 | ||
Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance | Q39085673 | ||
Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts | Q39266751 | ||
In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation. | Q39300631 | ||
Wnt5a signaling is a substantial constituent in bone morphogenetic protein-2-mediated osteoblastogenesis. | Q39345845 | ||
A conserved post-transcriptional BMP2 switch in lung cells | Q39708972 | ||
Hoxd13 binds in vivo and regulates the expression of genes acting in key pathways for early limb and skeletal patterning. | Q39992638 | ||
Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. | Q40130225 | ||
Bone morphogenetic proteins-2 and -4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells | Q40240703 | ||
Bone morphogenetic protein expression in human atherosclerotic lesions. | Q40304303 | ||
Conservation of Bmp2 post-transcriptional regulatory mechanisms | Q40516921 | ||
Osteoblast proliferation and maturation by bisphosphonates | Q40573161 | ||
BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop | Q40621832 | ||
NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro | Q40646195 | ||
Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction | Q40676346 | ||
Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes | Q40845725 | ||
Stimulation of bone formation in vitro and in rodents by statins | Q40914337 | ||
Bmp2 transcription in osteoblast progenitors is regulated by a distant 3' enhancer located 156.3 kilobases from the promoter | Q41975562 | ||
Wnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression. | Q42801437 | ||
Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. | Q44269091 | ||
Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes | Q44553793 | ||
An evolutionary and molecular analysis of Bmp2 expression | Q44752474 | ||
miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells | Q47861771 | ||
Transcriptional regulation of the Bmp2 gene. Retinoic acid induction in F9 embryonal carcinoma cells and Saccharomyces cerevisiae | Q47996305 | ||
Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells. | Q48006829 | ||
Bone morphogenetic proteins and a signalling pathway that controls patterning in the developing chick limb. | Q48086326 | ||
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect | Q48249566 | ||
miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. | Q50538051 | ||
Autoregulation of mouse BMP-2 gene transcription is directed by the proximal promoter element. | Q51064172 | ||
Retinoic acid regulates programmed cell death through BMP signalling. | Q52173225 | ||
Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation | Q79884998 | ||
A polymorphism in a conserved posttranscriptional regulatory motif alters bone morphogenetic protein 2 (BMP2) RNA:protein interactions | Q82646376 | ||
Bmp2 and Gata4 function additively to rescue heart tube development in the absence of retinoids | Q83324653 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | morphogenesis | Q815547 |
P304 | page(s) | 2127-2138 | |
P577 | publication date | 2015-03-16 | |
P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
P1476 | title | Turning Bone Morphogenetic Protein 2 (BMP2) on and off in Mesenchymal Cells | |
P478 | volume | 116 |
Q39497817 | Bone morphogenetic protein 2 (BMP2) may contribute to partition of energy storage into visceral and subcutaneous fat depots |
Q92035626 | Bone morphogenetic protein 2 is a depot-specific regulator of human adipogenesis |
Q48286499 | Characterization of new bone morphogenetic protein (Bmp)-2 regulatory alleles. |
Q37020852 | Competing Repressive Factors Control Bone Morphogenetic Protein 2 (BMP2) in Mesenchymal Cells |
Q30358100 | Effects of local delivery of BMP2, zoledronate and their combination on bone microarchitecture, biomechanics and bone turnover in osteoporotic rabbits |
Q47153019 | Enhancement of Bone Marrow-Derived Mesenchymal Stem Cell Osteogenesis and New Bone Formation in Rats by Obtusilactone A. |
Q55096315 | Expression and Dynamics of Podoplanin in Cultured Osteoblasts with Mechanostress and Mineralization Stimulus. |
Q39144038 | How long bones grow children: Mechanistic paths to variation in human height growth |
Q89522241 | Icariin promotes osteogenic differentiation of BMSCs by upregulating BMAL1 expression via BMP signaling |
Q41349109 | Increased microRNA-93-5p inhibits osteogenic differentiation by targeting bone morphogenetic protein-2. |
Q38804309 | Local and targeted drug delivery for bone regeneration |
Q92257469 | Modifications of Dental Implant Surfaces at the Micro- and Nano-Level for Enhanced Osseointegration |
Q92932503 | Structural determinants and genetic modifications enhance BMP2 stability and extracellular secretion |
Search more.